Why the study?
Are hs-cTnT levels associated with replacement fibrosis and progressive changes in left ventricular structure in CVD-free adults?
Are hs-cTnT levels associated with replacement fibrosis and progressive changes in left ventricular structure in CVD-free adults?
Minor elevations of hs-cTnT may serve as an early biochemical signature of subclinical cardiac disease, providing an opportunity for targeted preventive interventions.
hs-cTnT levels are associated with replacement fibrosis and progressive changes in left ventricular structure in CVD-free adults, findings that may precede HF symptoms by years. Minor elevations of hs-cTnT may represent a biochemical signature of early subclinical cardiac disease, providing an opportunity for targeted preventive interventions.
No takes yet. Share an insight, caveat, or question.
Seliger et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: